Global Huoxiangzhengqi Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Huoxiangzhengqi Market Research Report 2024
Huoxiang Zhengqi, the name of Chinese patent medicine, is an anti-heat agent, which has the effects of relieving exterior and removing dampness, regulating qi and harmonizing the middle. It is used for cold caused by exogenous wind-cold, internal injury damp stagnation, or summer injury and summer dampness.
According to Mr Accuracy reports’s new survey, global Huoxiangzhengqi market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Huoxiangzhengqi market research.
Key manufacturers engaged in the Huoxiangzhengqi industry include BEIJING TONG REN TANG, SHINEWAY, Xiuzheng Pharmaceutical Group, Taiji Holding Group, YUNNANBAIYAOGROUP, Tasly Pharmaceutical Group, Lanzhou Foci Pharmaceutical, Shanghai Baolong Anqing Pharmaceutical and CSPC Pharmaceutical Group, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Huoxiangzhengqi were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Huoxiangzhengqi market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Huoxiangzhengqi market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
BEIJING TONG REN TANG
SHINEWAY
Xiuzheng Pharmaceutical Group
Taiji Holding Group
YUNNANBAIYAOGROUP
Tasly Pharmaceutical Group
Lanzhou Foci Pharmaceutical
Shanghai Baolong Anqing Pharmaceutical
CSPC Pharmaceutical Group
Shuzhong Group
Sichuan Taihuatang Pharmaceutical
Sichuan Fuqing Pharmaceutical
Yunnan Yunlong Pharmaceutical
Chengdu Enwei Investment (GROUP)
Tengyao
Segment by Type
Pill
Capsule
Oral Liquid
Liquid
Powder
Granules
Hospital
Clinic
Pharmacy
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Huoxiangzhengqi report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Huoxiangzhengqi market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Huoxiangzhengqi market research.
Key manufacturers engaged in the Huoxiangzhengqi industry include BEIJING TONG REN TANG, SHINEWAY, Xiuzheng Pharmaceutical Group, Taiji Holding Group, YUNNANBAIYAOGROUP, Tasly Pharmaceutical Group, Lanzhou Foci Pharmaceutical, Shanghai Baolong Anqing Pharmaceutical and CSPC Pharmaceutical Group, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Huoxiangzhengqi were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Huoxiangzhengqi market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Huoxiangzhengqi market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BEIJING TONG REN TANG
SHINEWAY
Xiuzheng Pharmaceutical Group
Taiji Holding Group
YUNNANBAIYAOGROUP
Tasly Pharmaceutical Group
Lanzhou Foci Pharmaceutical
Shanghai Baolong Anqing Pharmaceutical
CSPC Pharmaceutical Group
Shuzhong Group
Sichuan Taihuatang Pharmaceutical
Sichuan Fuqing Pharmaceutical
Yunnan Yunlong Pharmaceutical
Chengdu Enwei Investment (GROUP)
Tengyao
Segment by Type
Pill
Capsule
Oral Liquid
Liquid
Powder
Granules
Segment by Application
Hospital
Clinic
Pharmacy
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Huoxiangzhengqi report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source